Brief: Illumina And Labcorp Expand Collaboration To Broaden Access To Precision Oncology Testing
March 18 (Reuters) - Illumina Inc ILMN.O: ILLUMINA AND LABCORP EXPAND COLLABORATION TO BROADEN ACCESS TO PRECISION ONCOLOGY TESTING ILLUMINA INC - NEW TEST DEVELOPMENT TO INCLUDE IVD TESTS FOR CGP AND WGS IN ONCOLOGY ILLUMINA INC - OFFERING TO PROVIDE PHARMACEUTICAL COMPANIES OPPORTUNITIES FOR COMPANION DIAGNOSTIC DEVELOPMENT Source text: ID:nPn7QV3v6a Further company coverage: ILMN.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Labcorp Holdings
See all newsBrief: Labcorp Declares Quarterly Dividend
Myriad jumps after agreeing to sell prenatal health testing business
Brief: Myriad Genetics To Sell Prenatal Health Testing Business To Labcorp
Live Markets: Split US congress after 2026 midterms could boost healthcare stocks, Mizuho says
Deals of the day-Mergers and acquisitions